IVF · INVO Fertility, Inc.

INVO Fertility received a Nasdaq deficiency notice on April 23, 2026, for failing to file its Form 10-K for the fiscal year ended December 31, 2025, by the April 15, 2026 deadline. The company has 60 calendar days to submit a plan to regain compliance. If accepted, Nasdaq may grant an exception until October 13, 2026. The delay is attributed to complex accounting issues, including tax provision, warrant accounting, and variable interest entity accounting. The stock continues to trade under the symbol 'IVF' with no immediate impact. This event signals potential financial reporting challenges and may affect investor confidence. The company's ability to file the 10-K and maintain listing is critical for its capital market access.